Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'21
Sep'21
Net Sales
2,07,925.74
2,33,181.85
2,03,566.71
2,06,625.92
2,01,299.52
1,43,576.20
1,27,496.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,07,925.74
2,33,181.85
2,03,566.71
2,06,625.92
2,01,299.52
1,43,576.20
1,27,496.75
Raw Material Cost
1,48,723.80
1,58,104.00
1,40,967.00
1,46,709.47
1,46,837.24
88,494.21
85,614.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
20,059.08
20,009.18
18,300.61
18,980.03
18,436.41
0.00
28,689.22
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9,914.30
10,755.57
9,874.72
10,194.89
8,686.53
5,900.59
5,159.64
Selling and Distribution Expenses
32,409.64
43,684.38
36,850.01
34,595.51
31,615.52
37,170.83
27,267.32
Other Expenses
-2,997.34
-3,076.48
-2,817.53
-2,917.49
-2,712.29
-590.06
-3,384.89
Total Expenditure (Excl Depreciation)
1,81,133.44
2,01,788.38
1,77,817.00
1,81,304.98
1,78,452.76
1,25,665.05
1,12,881.93
Operating Profit (PBDIT) excl Other Income
26792.3
31393.5
25749.699999999997
25320.9
22846.8
17911.199999999997
14614.8
Other Income
-106.42
-196.10
-39.49
-793.45
2,255.06
322.50
262.73
Operating Profit (PBDIT)
35,968.36
39,764.41
34,746.52
33,629.03
34,304.87
18,233.65
23,508.11
Interest
9,914.30
10,755.57
9,874.72
10,194.89
8,686.53
5,900.59
5,159.64
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
59,201.95
75,077.85
62,599.71
59,916.45
54,462.28
55,081.98
41,882.14
Depreciation
9,282.92
9,283.79
9,186.69
9,108.20
9,253.58
0.00
8,883.23
Profit Before Tax
16,771.13
19,725.04
15,685.11
14,325.93
16,364.76
12,333.06
9,465.24
Tax
3,270.37
5,088.58
2,855.85
2,617.57
3,272.95
2,193.68
1,893.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13,500.76
13,309.39
12,829.26
10,655.78
11,914.85
10,139.38
7,572.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13,500.76
13,309.39
12,829.26
10,655.78
11,914.85
10,139.38
7,572.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13,500.76
13,309.39
12,829.26
10,655.78
11,914.85
10,139.38
7,572.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
5,65,514.65
4,54,420.63
4,39,701.45
4,29,488.07
3,96,972.64
2,32,229.59
2,21,965.77
Earnings per share (EPS)
460.67
500.07
482.03
430.48
514.82
789.97
589.96
Diluted Earnings per share
460.67
500.07
482.03
430.48
514.82
789.97
589.96
Operating Profit Margin (Excl OI)
12.89%
13.16%
12.58%
12.25%
11.32%
12.48%
11.26%
Gross Profit Margin
12.53%
12.44%
12.22%
11.34%
12.73%
8.59%
14.39%
PAT Margin
6.49%
5.71%
6.3%
5.16%
5.92%
7.06%
5.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Analysis not available
Compare Quarterly Results Of Agimexpharm Pharmaceutical JSC With
Figures in Million
Consolidate Quarterly Results
Change(VND)
Change(%)
Net Sales
2,07,925.74
0
2,07,925.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,07,925.74
0
2,07,925.74
Raw Material Cost
1,48,723.80
0
1,48,723.80
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
20,059.08
0
20,059.08
Power Cost
0
0
0.00
Manufacturing Expenses
9,914.30
0
9,914.30
Selling and Distribution Expenses
32,409.64
0
32,409.64
Other Expenses
-2,997.34
0.00
-2,997.34
Total Expenditure (Excl Depreciation)
1,81,133.44
0
1,81,133.44
Operating Profit (PBDIT) excl Other Income
26,792.31
0.00
26,792.31
Other Income
-106.42
0
-106.42
Operating Profit (PBDIT)
35,968.36
0
35,968.36
Interest
9,914.30
0
9,914.30
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
59,201.95
0
59,201.95
Depreciation
9,282.92
0
9,282.92
Profit Before Tax
16,771.13
0
16,771.13
Tax
3,270.37
0
3,270.37
Provisions and contingencies
0
0
0.00
Profit After Tax
13,500.76
0
13,500.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
13,500.76
0
13,500.76
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13,500.76
0
13,500.76
Equity Capital
0
0
0.00
Face Value
10,000.00
0
0.00
Reserves
5,65,514.65
0
5,65,514.65
Earnings per share (EPS)
460.67
0
460.67
Diluted Earnings per share
460.67
0
460.67
Operating Profit Margin (Excl OI)
12.89%
0%
0.00
12.89%
Gross Profit Margin
12.53%
0%
0.00
12.53%
PAT Margin
6.49%
0%
0.00
6.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in Figures in Million
Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in Figures in Million
Quarterly - Interest
Interest NA Million
in Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in Figures in %






